Okujwayelekile Novalgina

-Delile
Okujwayelekile kwe-novalgine yi-sodium dipyrone, okuyiyona nto eyinhloko yalo muthi ovela elabhoratri yeSanofi-Aventis. I-sodium dipyrone, enguqulweni yayo ejwayelekile, nayo yenziwa ngamalabhorethri amaningana ezemithi afana neMedley, Eurofarma, EMS, Neo Química.
I-generic ye-novalgine ikhonjiswa njenge-analgesic ne-antipyretic futhi ingatholakala ngendlela yamaphilisi, amakhosethi noma isisombululo somjovo.
Izinkomba
Ubuhlungu nomkhuhlane.
Izimo
Iziguli ezine-hypersensitivity to dipyrone noma enye ingxenye yefomula, ekhulelwe, encelisa ibele, i-asthma, i-6-phosphate dehydrogenase yokushoda, izingane ezingaphansi kwezinyanga ezintathu noma ngaphansi kwe-5 kg, izingane ezingaphansi kweminyaka engu-4 (i-suppository), Izingane ezingaphansi konyaka owodwa (intravenous) , i-porphyria, ukungezwani komzimba nezidakamizwa, ukungezwani komzimba nezidakamizwa ze-pyrazoleonic, ukutheleleka okungapheli kokuphefumula.
Imiphumela emibi
Ukusabela kwe-hematological (ukunciphisa amangqamuzana amhlophe egazi), ukucindezela okuphansi kwesikhashana, ukubonakaliswa kwesikhumba (ukuqubuka) kungenzeka. Ezimweni ezingazodwa, i-Stevens-Johnson syndrome noma i-Lyell syndrome.
Isetshenziswa kanjani
Ukusetshenziswa ngomlomo
- Ithebhulethi engu-1000 mg:
- Abantu abadala nentsha engaphezu kweminyaka eyi-15: ½ ithebhulethi kuze kube izikhathi ezi-4 ngosuku noma ithebhulethi eli-1
kufika ezikhathini ezi-4 ngosuku.
- Abantu abadala nentsha engaphezu kweminyaka eyi-15: ½ ithebhulethi kuze kube izikhathi ezi-4 ngosuku noma ithebhulethi eli-1
- Ithebhulethi engu-500 mg
- Abantu abadala nentsha engaphezu kweminyaka engu-15: amaphilisi ayi-1 kuya kwangu-2 kuze kube izikhathi ezine ngosuku.
- Amaconsi:
- Abantu abadala nentsha engaphezu kweminyaka eyi-15:
- Amaconsi angama-20 kuye kwangama-40 ekuphathweni okukodwa noma afika kumaconsi angama-40 izikhathi ezine ngosuku.
- Izingane:
- Isisindo (isilinganiso seminyaka yobudala) Amaconsi e-Dose
5 kuya ku-8 kg umthamo owodwa 2 kuya ku-5 / (izinyanga ezi-3 kuya kwezingu-11) isilinganiso esiphezulu sama-20 (4 x 5) nsuku zonke - I-9 kuye ku-15 kg isilinganiso esisodwa 3 kuya ku-10 / (1 kuya eminyakeni emi-3) isilinganiso esiphezulu sama-40 (4 x 10) nsuku zonke
- 16 to 23 kg single dose 5 to 15 / (4 to 6 years) maximum dose 60 (4 x 15) nsuku zonke
- 24 to 30 kg single dose 8 to 20 / (7 to 9 years) maximum dose 80 (4 x 20) nsuku zonke
- 31 to 45 kg single dose 10 to 30 / (10 to 12 years) maximum dose 120 (4 x 30) nsuku zonke
- 46 kuya ku-53 kg umthamo owodwa 15 kuya ku-35 / (iminyaka eyi-13 kuya kwengu-14) isilinganiso esiphezulu se-140 (4 x 35) nsuku zonke
- Isisindo (isilinganiso seminyaka yobudala) Amaconsi e-Dose
- Izingane ezingaphansi kwezinyanga ezintathu noma ezinesisindo esingaphansi kuka-5 kg akufanele ziphathwe ngeNovalgina, ngaphandle kwalapho kudingekile impela.
- Abantu abadala nentsha engaphezu kweminyaka eyi-15:
Ukusetshenziswa Okuphelele
- Abantu abadala nentsha engaphezu kweminyaka engu-15: i-1 suppository kuze kube izikhathi ezine ngosuku.
- Izingane ezineminyaka engaphezu kwengu-4: i-1 suppository kuze kube izikhathi ezine ngosuku.
- Izingane ezingaphansi kweminyaka engu-4 noma ngaphansi kuka-16 kg akufanele ziphathwe ngama-suppositories.
Ukusetshenziswa ngomjovo
- Abantu abadala nentsha engaphezu kweminyaka engu-15: ngomthamo owodwa we-2 kuya ku-5 ml (ngemithambo yegazi noma ngemithambo); isilinganiso esiphezulu sansuku zonke se-10 ml.
- Izingane kanye nezinsana: ngaphansi konyaka owodwa ubudala wokujova i-NOVALGINE kufanele inikezwe nge-intramuscularly kuphela.
- Izingane
- Izinsana ezisuka ku-5 kuye ku-8 kg - 0.1 - 0.2 ml
- Izingane ezisuka ku-9 kuye ku-15 kg 0.2 - 0.5 ml 0.2 - 0.5 ml
- Izingane ezisuka ku-16 kuye ku-23 kg 0.3 - 0.8 ml 0.3 - 0.8 ml
- Izingane ezisuka ku-24 kuye ku-30 kg 0.4 - 1 ml 0.4 - 1 ml
- Izingane ezisuka ku-31 kuye ku-45 kg 0.5 - 1.5 ml 0.5 - 1.5 ml
- Izingane ezisuka ku-46 kuye ku-53 kg 0.8 - 1.8 ml 0.8 - 1.8 ml
Amanani aphethwe kufanele aqondiswe udokotela wakho.